Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH

Thrombosis Research

Volumn 131, Issue 2, 2013, Pages 178-182

  Narverud, Ingunn ^a,b,c   Iversen, Per Ole ^a,d   Aukrust, Pål ^a,c   Halvorsen, Bente ^a,c   Ueland, Thor ^a,c   Johansen, Siril G ^c,e   Nenseter, Marit S ^c   Sandset, Per Morten ^a,c,d   Ulven, Stine M ^b   Ose, Leiv ^a,c   Retterstøl, Kjetil ^a,c   Holven, Kirsten B ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Axellus   (Norway)

Author keywords

Atherosclerosis; Children; Haemostatic and fibrinolytic markers; Maternal familial hypercholesterolaemia

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; BIRTH; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; MATERNAL DISEASE; MATERNAL FAMILIAL HYPERCHOLESTEROLAEMIA; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; CHILD; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; RISK FACTORS;

EID: 84872310337     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.11.008     Document Type: Article

References (31)

1. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
2. W.B. Kannel Overview of hemostatic factors involved in atherosclerotic cardiovascular disease Lipids 40 2005 1215 1220
3. A.D. Blann, J. Amiral, C.N. McCollum, and G.Y. Lip Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls Atherosclerosis 152 2000 29 34
4. T. Sakata, T. Mannami, S. Baba, Y. Kokubo, K. Kario, and A. Okamoto Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries Atherosclerosis 176 2004 355 360
5. V. Salomaa, C. Matei, N. Aleksic, L. Sansores-Garcia, A.R. Folsom, and H. Juneja Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study Lancet 353 1999 1729 1734
6. V.E. Gerdes, J.A. Kremer Hovinga, H. Ten Cate, D.P. Brandjes, and H.R. Buller Soluble thrombomodulin in patients with established atherosclerosis J Thromb Haemost 2 2004 200 201
7. T. Hoekstra, J.M. Geleijnse, E.G. Schouten, and C. Kluft Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk Thromb Haemost 91 2004 861 872
8. P. Eriksson, B. Kallin, F.M. van 't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci U S A 92 1995 1851 1855
9. D. Ardissino, P.A. Merlini, R. Ariens, R. Coppola, E. Bramucci, and P.M. Mannucci Tissue-factor antigen and activity in human coronary atherosclerotic plaques Lancet 349 1997 769 771
10. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47
11. L. Ose Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children Semin Vasc Med 4 2004 51 57
12. D. Marks, M. Thorogood, H.A. Neil, and S.E. Humphries A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia Atherosclerosis 168 2003 1 14
13. K.B. Holven, A.M. Myhre, P. Aukrust, T.A. Hagve, L. Ose, and M.S. Nenseter Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender Eur Heart J 24 2003 1756 1762
14. I. Narverud, T. Ueland, M.S. Nenseter, K. Retterstol, V.H. Telle-Hansen, and B. Halvorsen Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor alpha system and interleukin-10 Atherosclerosis 214 2011 163 168
15. U. Martin, C. Davies, S. Hayavi, A. Hartland, and F. Dunne Is normal pregnancy atherogenic? Clin Sci (Lond) 96 1999 421 425
16. A.L. Amundsen, J. Khoury, P.O. Iversen, C. Bergei, L. Ose, and S. Tonstad Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia Atherosclerosis 189 2006 451 457
17. A.L. Amundsen, J. Khoury, P.M. Sandset, I. Seljeflot, L. Ose, and S. Tonstad Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia Thromb Res 120 2007 21 27
18. C. Napoli, F.P. D'Armiento, F.P. Mancini, A. Postiglione, J.L. Witztum, and G. Palumbo Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions J Clin Invest 100 1997 2680 2690
19. C. Napoli, C.K. Glass, J.L. Witztum, R. Deutsch, F.P. D'Armiento, and W. Palinski Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study Lancet 354 1999 1234 1241
20. A. van der Graaf, M.N. Vissers, D. Gaudet, D. Brisson, S. Sivapalaratnam, and T.J. Roseboom Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring Arterioscler Thromb Vasc Biol 30 2010 2673 2677
21. J. Versmissen, I.P. Botden, R. Huijgen, D.M. Oosterveer, J.C. Defesche, and T.C. Heil Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality Atherosclerosis 219 2011 690 693
22. P. Aukrust, T. Ueland, F. Muller, A.K. Andreassen, I. Nordoy, and H. Aas Elevated circulating levels of C-C chemokines in patients with congestive heart failure Circulation 97 1998 1136 1143
23. M. Charakida, D. Tousoulis, I. Skoumas, C. Pitsavos, C. Vasiliadou, and E. Stefanadi Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia Atherosclerosis 204 2009 532 537
24. M. Sebestjen, B. Zegura, B. Guzic-Salobir, and I. Keber Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia Wien Klin Wochenschr 113 2001 113 118
25. C.T. Mitchell, A. Kamineni, W. Palmas, and M. Cushman Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis Atherosclerosis 207 2009 277 283
26. H. Soejima, H. Ogawa, H. Yasue, K. Kaikita, K. Nishiyama, and K. Misumi Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina Circulation 99 1999 2908 2913
27. W. Palinski, E. Nicolaides, A. Liguori, and C. Napoli Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease J Cardiovasc Transl Res 2 2009 277 285
28. J. Khoury, A.L. Amundsen, S. Tonstad, T. Henriksen, L. Ose, and K. Retterstol Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia Acta Obstet Gynecol Scand 88 2009 222 226
29. T. Ueland, M.N. Vissers, A. Wiegman, J. Rodenburg, B. Hutten, and L. Gullestad Increased inflammatory markers in children with familial hypercholesterolaemia Eur J Clin Invest 36 2006 147 152
30. S. de Jongh, M.R. Lilien, J. op't Roodt, E.S. Stroes, H.D. Bakker, and J.J. Kastelein Early statin therapy restores endothelial function in children with familial hypercholesterolemia J Am Coll Cardiol 40 2002 2117 2121
31. F.J. Raal, and R.D. Santos Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment Atherosclerosis 223 2012 262 268